Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022
S8), Pleural effusion (RR 0.73, 95% CI 0.481.11, p = 0.15
This is a critical differentiator, especially for aging adults or individuals managing coexisting health conditions who are wary of aggressive formulations that can disrupt sleep, raise blood pressure, or cause jittery side effects
Wear UPF 50+ Protective Clothing Clothing is your first line of defense
Overall, the plan is ambitious, but most, if any, benefits will have to be determined after it is functioning, Kelley said
